SLC35B3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.041000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.563400E-01
Normal-vs-Stage2
8.223800E-01
Normal-vs-Stage3
9.168100E-02
Normal-vs-Stage4
2.370800E-01
Stage1-vs-Stage2
6.233200E-01
Stage1-vs-Stage3
3.240000E-01
Stage1-vs-Stage4
7.319200E-01
Stage2-vs-Stage3
2.693000E-01
Stage2-vs-Stage4
1.863350E-01
Stage3-vs-Stage4
2.638200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.879600E-01
Normal-vs-AfricanAmerican
8.887200E-01
Normal-vs-Asian
9.841600E-01
Caucasian-vs-AfricanAmerican
8.047800E-01
Caucasian-vs-Asian
6.520200E-01
AfricanAmerican-vs-Asian
9.376600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.246600E-01
Normal-vs-Female
7.865800E-01
Male-vs-Female
9.899400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.588420E-01
Normal-vs-Age(41-60Yrs)
7.131400E-01
Normal-vs-Age(61-80Yrs)
8.299800E-01
Normal-vs-Age(81-100Yrs)
9.817400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.252220E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.443000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.413800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.796200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.805800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.495400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.834600E-01
Normal-vs-Daily Drinker
7.190100E-02
Normal-vs-Weekly Drinker
8.952200E-01
Normal-vs-Occasional Drinker
6.657200E-01
Normal-vs-Social Drinker
9.969800E-01
Non Drinker-vs-Daily Drinker
9.161600E-02
Non Drinker-vs-Weekly Drinker
7.356200E-01
Non Drinker-vs-Occasional Drinker
9.220800E-01
Non Drinker-vs-Social Drinker
5.958200E-01
Daily Drinker-vs-Weekly Drinker
2.778300E-02
Daily Drinker-vs-Occasional Drinker
2.043500E-02
Daily Drinker-vs-Social Drinker
3.771600E-02
Weekly Drinker-vs-Occasional Drinker
7.262400E-01
Weekly Drinker-vs-Social Drinker
8.450800E-01
Occasional Drinker-vs-Social Drinker
5.664000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.270640E-01
Normal-vs-Grade 2
7.459600E-02
Normal-vs-Grade 3
7.301600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.761390E-01
Grade 1-vs-Grade 3
4.437000E-01
Grade 1-vs-Grade 4
1.270640E-01
Grade 2-vs-Grade 3
4.885000E-01
Grade 2-vs-Grade 4
7.459600E-02
Grade 3-vs-Grade 4
7.301600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.943200E-01
Normal-vs-NonDiabetic
6.039200E-01
Diabetic-vs-NonDiabetic
9.182400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.106960E-01
Normal-vs-NoPancreatitis
7.540400E-01
Pancreatitis-vs-NoPancreatitis
7.250200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.829800E-01
Normal-vs-N1
8.051200E-01
N0-vs-N1
8.973200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.774400E-01
Normal-vs-TP53-NonMutant
7.690600E-01
TP53-Mutant-vs-TP53-NonMutant
4.429200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
